July 15, 2021
Reston, VA—The Journal of Nuclear Medicine (JNM) has published a special supplement highlighting molecular imaging advances in the field of endocrinology. The supplement focuses on the most novel approaches and cutting-edge clinical and scientific information regarding diagnostic nuclear imaging for several endocrine disorders, including thyroid disease, thyroid nodules, adrenal masses, congenital hyperinsulinism, pituitary adenomas, and more.
Nuclear medicine has always been an important component of endocrinology and continues to expand the understanding of endocrine diseases. Recent improvements in instrumentation and new radiopharmaceuticals have expanded the scope and use of nuclear endocrinology.
“The diversity of molecular targets uniquely expressed by endocrine tumors provides opportunities for enhanced characterization of these tumors with molecular imaging,” said David Taïeb, MD, PhD, JNM supplement editor. “Radiopharmaceuticals in endocrine applications serve not only as diagnostic agents, but also as a platform to treat patients with matched radionuclide therapy agents using a theranostic approach.”
Articles in the supplement include:
“The future for nuclear endocrinology is bright,” said JNM Editor-in-Chief Johannes Czernin, MD. “The clinical translation of new radiopharmaceuticals, together with PET technologic improvements, will lead to advances in the care of patients with endocrine disorders. This JNM supplement will be a helpful resource for practicing physicians in nuclear medicine, endocrinology and oncology as well as other healthcare professionals.”
The JNM supplement was created to be a resource for practicing physicians, including nuclear medicine specialists, radiologists, endocrinologists, and oncologists, as well as fellows in training, students, and other health care professionals. The supplement was edited by David Taïeb, MD, PhD, Elif Hindié, MD, PhD, and David Mankoff, MD, PhD.
The JNM Endocrinology Supplement is available at https://jnm.snmjournals.org/content/62/Supplement_2.
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. For complimentary media access to articles or to schedule an interview with a researcher, please contact Rebecca Maxey at (703) 652-6772 or firstname.lastname@example.org
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed more than 11 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.